The Italian Transthyretin Amyloidosis Web-Network
The Italian Transthyretin Amyloidosis Web-Network (ITA-WebNet)
Fondazione IRCCS Policlinico San Matteo di Pavia
1,000 participants
Jul 13, 2022
OBSERVATIONAL
Conditions
Summary
The study aims, by generating a large registry of patients with ATTR amyloidosis, including data at diagnosis and during follow up, to describe the natural history of ATTR amyloidosis in a real-world setting and to define and validate prognostic models, response criteria applicable at any point of the disease. The registry will also be used for data sharing and to allow the possibility of a close collaboration amongst the amyloidosis experts of the ARTC and all the physicians around the Country involved in the diagnosis and management of systemic amyloidosis. Thanks to the online registry, the diagnostic facility of the ARTC will be made available to requesting physicians.
Eligibility
Inclusion Criteria4
- Suspected diagnosis of systemic and localized amyloidosis;
- age .18 years;
- ability to understand and willingness to sign an informed consent (patients who already sign informed consent for clinical data to be used in retrospective analyses will be accepted);
- planned (or ongoing) follow-up at participating center.
Exclusion Criteria1
- \. Diagnosis of light chain (AL) amyloidosis
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(30)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05444920